Watch one patient's story of receiving cell therapy treatment
When his lymphoma grew faster than expected, Paul Chae was treated with CAR-T cell therapy at Massachusetts General Hospital. This therapy represents a significant step forward in the development of immunotherapies - therapies that use a patient's own immune system to combat their disease. Paul is now cancer free thanks to this innovative technology.
Cell therapy products for T cell, MSC, PSC, NSC, and HSC
One aspect of successfully transitioning your cell therapy to the clinic involves the careful selection of products from a reliable supplier. Based on your starting cell type (T cells, MSCs, PSCs, NSCs, or HSCs), our interactive product selection tool will help you identify reagents, services, and support that can scale with you from discovery to commercialization.
For Research Use Only. Not for use in diagnostic procedures.